Clinical Trial Update: Anti-thrombin III (ATIII) vs Placebo in Children (<7mo) Undergoing Open Congenital Cardiac Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating anti-thrombin III versus placebo in young infants undergoing open congenital cardiac surgery has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antithrombin Iii Deficiency
• Congenital Heart Disease

Drugs mentioned

• Anti-thrombin III (ATIII) (antithrombin III)

Snippet

Sponsor: Duke University | Conditions: ATIII Deficiency | Phase 2 | Status: COMPLETED | Results posted: 2017-07-26